Iktos and Elsevier partner to deliver a predictive retrosynthesis and synthetic accessibility platform. Combining the world’s largest chemistry database, Reaxys from Elsevier, with cutting-edge AI from Iktos, the advanced platform will enable pharmaceutical companies to identify pre-clinical drug candidates faster. Follow the link for the full press release.
